Physician profile
George V Schaefer
NPI 1700834603
$1,624.15
in general payments reported to CMS, 2019-2025
18 companies · $224 in 2025
The $224 reported for 2025 was more than what 77% of Adolescent Medicine (Pediatrics) providers received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73.98 · 2020: $194 · 2021: $211 · 2022: $308 · 2023: $368 · 2024: $246 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $838.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $837.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $499.33 | 2019-2025 | Bexsero, Pediarix, Rotarix |
| Pfizer INC. | $305.11 | 2022-2025 | |
| Sanofi Pasteur INC. | $198.46 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $126.52 | 2020-2024 | Capvaxive, Gardasil 9, Vaxneuvance |
| Amgen INC. | $90.89 | 2022-2024 | Repatha, Otezla |
| Novo Nordisk INC | $75.94 | 2020-2025 | Wegovy |
| Dexcom, INC. | $68.00 | 2021-2023 | Dexcom G6 Transmitter |
| Genentech USA, INC. | $51.11 | 2020-2021 | |
| Alfasigma USA, INC. | $34.04 | 2022 | |
| Sanofi-Aventis U.S. LLC | $32.95 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.00 | 2019-2023 | Trulance, Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $20.40 | 2020 | |
| Supernus Pharmaceuticals, INC. | $19.84 | 2022 | |
| Dynavax Technologies Corporation | $19.18 | 2023 | Heplisav-B |
| Biohaven Pharmaceutical Holding Company LTD. | $16.84 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $12.59 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $12.06 | 2021 | |
| Shire North American Group INC | $10.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Schaefer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.